Glenmark Pharmaceuticals announced that it has received approval from the Ministry of
Healthcare, Russia to market Momate Rhino (Mometasone Furoate 50 mcg) metered nasal spray as
an over]the]counter (OTC) product for the treatment of seasonal and perennial allergic rhinitis in
patients above 18 years of age.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
